Literature DB >> 24534028

Stroke- on- Awakening: Safety of CT-CTA Based Selection for Reperfusion Therapy.

Simerpreet Bal, Rohit Bhatia, Nandavar Shobha, Bijoy K Menon, Sung Il Sohn, Mayank Goyal, Andrew M Demchuk, Michael D Hill.   

Abstract

BACKGROUND: We studied the safety of use of acute reperfusion therapies in patients with stroke- on- awakening using a computed tomographic angiography (Cta) based large vessel occlusion-good scan paradigm in clinical routine.
METHODS: the Cta database of the Calgary stroke program was reviewed for the period January 2003-March 2010. patients with stroke-on-awakening with large artery occlusions on Cta, who received conservative, iV thrombolytic and/or endovascular treatment at discretion of the attending stroke neurologist were analyzed. time of onset was defined by the time last seen or known to be normal. Baseline non-contrast Ct scan (nCCt) alberta Stroke program early Ct Score (aSpeCtS) > 7 was considered a good scan. hemorrhage was defined on follow-up brain imaging using eCaSS 3 criteria. independence (mrS≤2) at three months was considered a good clinical outcome. Standard descriptive statistics and multivariable analysis were done.
RESULTS: among 532 patients with large artery occlusions, 70 patients with stroke-on-awakening (13.1%) were identified. the median age was 69.5 (iQr 24) and 41 (58.6%) were female; 41 (58.6%) received anti-platelets only and 29 (41.4%) received thrombolytic treatment [iV-12 (17.1%), iV/ia-12 (17.1%) and ia-5(7.1%)]. unadjusted analysis showed that baseline nCCt aSpeCtS ≤ 7 (p=0.002) and higher nihSS scores (p=0.018) were associated with worse outcomes. there were no ph2 hemorrhages in the iV thrombolytic or endovascular treated group. functional outcome was not different by treatment.
CONCLUSION: When carefully selected using Ct –Cta, by a good scan (aSpeCtS > 7) occlusion paradigm, acute reperfusion therapies in patients with stroke-on-awakening can be performed safely in clinical routine.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24534028     DOI: 10.1017/s0317167100016553

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  5 in total

1.  Rapid endovascular treatment for stroke.

Authors:  Faizan Khan; Satya Patro; Daniela Iancu
Journal:  CMAJ       Date:  2015-10-19       Impact factor: 8.262

2.  Time for a Time Window Extension: Insights from Late Presenters in the ESCAPE Trial.

Authors:  J W Evans; B R Graham; P Pordeli; F S Al-Ajlan; R Willinsky; W J Montanera; J L Rempel; A Shuaib; P Brennan; D Williams; D Roy; A Y Poppe; T G Jovin; T Devlin; B W Baxter; T Krings; F L Silver; D F Frei; C Fanale; D Tampieri; J Teitelbaum; D Iancu; J Shankar; P A Barber; A M Demchuk; M Goyal; M D Hill; B K Menon
Journal:  AJNR Am J Neuroradiol       Date:  2017-11-30       Impact factor: 3.825

Review 3.  Safety of intravenous thrombolysis in stroke of unknown time of onset: A systematic review and meta-analysis.

Authors:  Chen Wang; Wanting Wang; Jianling Ji; Jian Wang; Ruijun Zhang; Yujie Wang
Journal:  J Thromb Thrombolysis       Date:  2021-05-07       Impact factor: 2.300

4.  Efficacy and Safety of Intravenous Thrombolysis in Patients with Unknown Onset Stroke: A Meta-Analysis.

Authors:  Di Luan; Yuanxiang Zhang; Qian Yang; Zhiming Zhou; Xianjun Huang; Shoucai Zhao; Lili Yuan
Journal:  Behav Neurol       Date:  2019-09-03       Impact factor: 3.342

5.  Efficacy and safety of rt-PA intravenous thrombolysis in patients with wake-up stroke: A meta-analysis.

Authors:  Hongfa Liu; Weihua Hu; Fang Zhang; Wei Gu; Jiankun Hong; Jianping Chen; Ying Huang; Huoying Pan
Journal:  Medicine (Baltimore)       Date:  2022-02-18       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.